COL1A1 and neoplasm: The results indicated that high COL1A1 expression was significantly associated with poor prognosis in tumor subgroups with enriched B cells (HR=1.43, p=0.04) (Figure 5A), as well as in cohorts with enriched macrophages (HR=1.54, p=0.016) and decreased macrophages(HR=1.57, p=0.046) (Figure 5B).